Keliomics

Keliomics is a small biotechnology company headquartered in the United States. With a team of five employees, the company generates an annual revenue of $2.5 million. Keliomics is dedicated to transforming cancer treatment through groundbreaking technology. At the core of Keliomics's work is a revolutionary method that allows for the preservation of human tissues and tumors outside the body. This innovative approach opens up new possibilities for research, diagnostics, and personalized cancer therapies. Keliomics's unique technology holds the potential to significantly impact the field of oncology. By keeping tissues and tumors viable outside the body, researchers and clinicians can gain deeper insights into tumor biology and develop more effective targeted treatments. For more information about Keliomics and its groundbreaking technology, please visit keliomics.com.